Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4378.00 | 4227.00 | 1.0357 | 1.0641 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4150.00 | 4227.00 | 0.9818 | 0.9672 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 3433.00 | 4227.00 | 0.8122 | 0.6588 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 3614.00 | 4227.00 | 0.8550 | 0.7372 | |
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 2500.00 | 1955.17 | 3473.00 | 4227.00 | 0.8216 | 0.6762 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 2500.00 | 1955.17 | 4092.00 | 4227.00 | 0.9681 | 0.9425 |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4077.00 | 4227.00 | 0.9645 | 0.9361 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 8 | 2500.00 | 1955.17 | 2530.00 | 4227.00 | 0.5985 | 0.2608 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 8 | 2500.00 | 1955.17 | 3746.00 | 4227.00 | 0.8862 | 0.7942 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 2500.00 | 1955.17 | 2084.00 | 4227.00 | 0.4930 | 0.0590 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 2500.00 | 1955.17 | 3161.00 | 4227.00 | 0.7478 | 0.5402 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 2500.00 | 1955.17 | 3395.00 | 4227.00 | 0.8032 | 0.6423 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 2500.00 | 1955.17 | 4077.00 | 4227.00 | 0.9645 | 0.9361 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 8 | 2500.00 | 1955.17 | 4164.00 | 4227.00 | 0.9851 | 0.9732 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 2500.00 | 1955.17 | 4469.00 | 4227.00 | 1.0573 | 1.1026 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 2500.00 | 1955.17 | 2500.00 | 4227.00 | 0.5914 | 0.2473 |
| SK-BR-3 | Linsitinib | 10 | uM | 8 | 2500.00 | 1955.17 | 3113.00 | 4227.00 | 0.7365 | 0.5191 |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4017.00 | 4227.00 | 0.9503 | 0.9105 | |
| SK-BR-3 | Lapatinib | 1 | uM | 8 | 2500.00 | 1955.17 | 1931.00 | 4227.00 | 0.4568 | -0.0111 |
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 2500.00 | 1955.17 | 1970.00 | 4227.00 | 0.4661 | 0.0068 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 8 | 2500.00 | 1955.17 | 4003.00 | 4227.00 | 0.9470 | 0.9045 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 8 | 2500.00 | 1955.17 | 4345.00 | 4227.00 | 1.0279 | 1.0501 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 8 | 2500.00 | 1955.17 | 2970.00 | 4227.00 | 0.7026 | 0.4563 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 8 | 2500.00 | 1955.17 | 2120.00 | 4227.00 | 0.5015 | 0.0755 |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4288.00 | 4227.00 | 1.0144 | 1.0259 |